britain
drew
scientific
group
plc
said
friday
evaluating
effectiveness
proprietary
technology
onset
cardiovascular
disease.the
company
share
price
rise
28-1/2
pence
191
said
investigating
feasibility
testing
g100
series
instrumentation.the
company
did
say
long
carry
evaluation
london
newsroom
44
171
542
4366
